Stock Events

Stock Events

Bionano Genomics 

$1.2000
1086
-$0.04-3.23% Friday 20:00
+$0.01+0.83%Friday 23:37After hours

Statistics

Day High
1.25
Day Low
1.195
52W High
5.5
52W Low
1
Volume
174,894
Avg. Volume
138,409
Mkt Cap
14.13M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-31.2
-20.95
-10.7
-0.45
Expected EPS
-0.45
Actual EPS
N/A

Financials

-92.59%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
28.51MRevenue
-26.4MNet Income

Analyst Ratings

6.00Average Price Target
The highest estimate is 6.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BNGO. It's not an investment recommendation.
NIO
234
NIO
Apple
203
AAPL
Tesla
198
TSLA
Palantir Technologies
186
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers long-read sequencing technologies that compete with Bionano's optical genome mapping solutions for complex genetic research and diagnostics.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics market space that Bionano targets.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of instruments and reagents for genomic research, including next-generation sequencing, competing with Bionano's genomic analysis technologies.
Agenus
AGEN
Mkt Cap344.77M
Agilent Technologies provides instruments, software, services, and consumables for the entire laboratory workflow, including genomics research, competing with Bionano's offerings.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen offers sample to insight solutions, including next-generation sequencing and molecular diagnostics that compete with Bionano's genomic analysis solutions.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is involved in CRISPR/Cas9 technology for genome editing, which competes indirectly with Bionano's genomic mapping and analysis technologies by offering alternative approaches to genetic research and diagnostics.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine operates in the genome editing space using CRISPR technology, offering a competitive alternative to Bionano's genomic analysis and mapping solutions.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is focused on developing gene-based medicines using CRISPR/Cas9 technologies, indirectly competing with Bionano's genomic analysis tools by providing alternative methods for genetic research.
Twist Bioscience
TWST
Mkt Cap8.87B
Twist Bioscience operates in the synthetic biology and genomics field, producing synthetic DNA that is used in genetic research, competing with Bionano's genomic analysis and mapping technologies.

About

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Show more...
CEO
Albert A. Luderer
Employees
97
Country
United States
ISIN
US09075F4046
WKN
000A3ENV3

Listings

STU
DE
2Y30.STU
MU
DE
2Y3.MU
MU
DE
2Y30.MU
XNAS
US
BNGO

0 Comments

Share your thoughts

FAQ

What is Bionano Genomics stock price today?▼
The current price of BNGO is $1.20 USD — it has decreased by -3.23% in the past 24 hours. Watch Bionano Genomics stock price performance more closely on the chart.
What is Bionano Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Bionano Genomics stocks are traded under the ticker BNGO.
Is Bionano Genomics stock price growing?▼
BNGO stock has risen by +2.56% compared to the previous week, the month change is a +12.15% rise, over the last year Bionano Genomics has showed a -69.92% decrease.
What is Bionano Genomics market cap?▼
Today Bionano Genomics has the market capitalization of 14.13M
When is the next Bionano Genomics earnings date?▼
Bionano Genomics is going to release the next earnings report on October 29, 2026.
What were Bionano Genomics earnings last quarter?▼
BNGO earnings for the last quarter are -0.66 USD per share, whereas the estimation was -0.67 USD resulting in a +1.49% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bionano Genomics revenue for the last year?▼
Bionano Genomics revenue for the last year amounts to 28.51M USD.
What is Bionano Genomics net income for the last year?▼
BNGO net income for the last year is -26.4M USD.
How many employees does Bionano Genomics have?▼
As of September 05, 2026, the company has 97 employees.
In which sector is Bionano Genomics located?▼
Bionano Genomics operates in the Health & Wellness sector.
When did Bionano Genomics complete a stock split?▼
The last stock split for Bionano Genomics was on January 27, 2025 with a ratio of 1:60.
Where is Bionano Genomics headquartered?▼
Bionano Genomics is headquartered in SAN DIEGO, United States.